基本信息
views: 206
Career Trajectory
Bio
We study the biology of immune cells and their roles in the pathogenesis of cancers and other life-threatening diseases. By applying new and more precise analytical tools for assessing this system in mice and humans, we have been successful at identifying disease-promoting immune abnormalities. By targeting the cells responsible for or affected by these abnormalities, we have succeeded in reversing the abnormalities and ameliorating the diseases they cause. We make extensive use of mouse models for in depth mechanistic studies, but we also use human tissues to confirm the clinical relevance of our findings. To pursue this work, we have been using newer multiplex imaging technologies and deep gene sequencing.
Research Interests
Papers共 333 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Weiguo Fan,Kolade Adebowale,Lóránd Váncza,Yuan Li, Md Foysal Rabbi,Koshi Kunimoto,Dongning Chen,Gergely Mozes,David Kung-Chun Chiu,Yisi Li,Junyan Tao,Yi Wei,Nia Adeniji,Ryan L. Brunsing,Renumathy Dhanasekaran,Aatur Singhi,David Geller,Su Hao Lo,Louis Hodgson,Edgar G. Engleman,Gregory W. Charville,Vivek Charu,Satdarshan P. Monga,Taeyoon Kim,Rebecca G. Wells,Ovijit Chaudhuri,Natalie J. Török
NATUREno. 7999 (2024)
Jiping Sun,Youqin Zhang, Qingbing Zhang,Lin Hu, Linfeng Zhao,Hongdong Wang,Yue Yuan,Hongshen Niu,Dongdi Wang,Huasheng Zhang,Jianyue Liu, Xujiao Feng,Xiaohui Su,Ju Qiu,Jing Sun,Heping Xu, Catherine Zhang, Kathleen Wang,Yan Bi,Edgar G. Engleman,Lei Shen
IMMUNITYno. 6 (2024)
Cancer Researchno. 7_Supplement (2023): 66-66
crossref(2023)
Trends in cell biologyno. 12 (2023): 1021-1034
CANCER RESEARCHno. 7 (2023)
crossref(2023)
Regular and Young Investigator Award Abstracts (2023)
openalex(2023)
Load More
Author Statistics
#Papers: 332
#Citation: 24260
H-Index: 81
G-Index: 149
Sociability: 7
Diversity: 3
Activity: 254
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn